After months of debate accompanied by studies, the European Medicines Agency stated on Tuesday that messenger RNA (mRNA) COVID-19 vaccines do not cause complications for pregnant women or fetuses. The European Medicines Agency noted that the review, which relied on studies involving approximately 65,000 pregnancies at various stages, found no signs of increased risk of complications, miscarriage, premature birth, or serious side effects on fetuses after receiving these vaccines. Pfizer and its German partner BioNTech, along with Moderna, currently provide such vaccines to the European Union.
Despite acknowledging some shortcomings in the data, the agency stated that the results were consistent across all studies. The agency declared: "The benefits of receiving mRNA COVID-19 vaccines during pregnancy outweigh any potential risks to pregnant women and fetuses.” The internal review team also concluded that COVID-19 vaccines based on this technology are effective in reducing the risks of hospitalization and death among pregnant women, as they are among non-pregnant individuals.
